Integra LifeSciences to Host Q4 and Full Year 2025 Earnings Call

The medical technology company will discuss its 2025 financial results on February 26, 2026.

Published on Feb. 9, 2026

Got story updates? Submit your updates here. ›

Integra LifeSciences Holdings Corporation, a leading global medical technology company, will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. The company's management team will host a conference call at 8:30 a.m. ET to discuss the results.

Why it matters

As a major player in the medical technology industry, Integra LifeSciences' quarterly and annual financial performance is closely watched by investors, analysts, and the broader healthcare community. The company's earnings call will provide insights into its operational and financial health, as well as its strategic priorities going forward.

The details

The live webcast of the conference call will be available on the Investors section of Integra LifeSciences' website. Participants can register in advance to receive dial-in details and an individual pin. A webcast replay of the call will also be accessible on the company's website following the event.

  • Integra LifeSciences will release its Q4 and full year 2025 financial results on February 26, 2026.
  • The earnings conference call will be held at 8:30 a.m. ET on February 26, 2026.

The players

Integra LifeSciences Holdings Corporation

A leading global medical technology company that is dedicated to restoring lives through innovative products and solutions in neurosurgery and tissue reconstruction.

Chris Ward

The Investor Relations representative for Integra LifeSciences.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Integra LifeSciences' earnings call for insights into the company's financial performance, strategic priorities, and market outlook.

The takeaway

Integra LifeSciences' upcoming earnings report and conference call will provide a valuable update on the company's progress and position within the highly competitive medical technology industry.